Menu Search
Equities

Jinhai Medical Technology Ltd

2225:HKG.HS

Jinhai Medical Technology Ltd

Actions
  • Price (HKD)6.23
  • Today's Change0.03 / 0.48%
  • Shares traded1.11m
  • 1 Year change+213.07%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SGDIncome statement in SGDView more

Year on year Jinhai Medical Technology Ltd had net income fall from a gain of 468.09k to a loss of 3.14m despite a 104.87% increase in revenues from 22.28m to 45.64m. An increase in the cost of goods sold as a percentage of sales from 54.60% to 73.65% was a component in the falling net income despite rising revenues.
Gross margin24.17%
Net profit margin-17.87%
Operating margin-15.48%
Return on assets-19.04%
Return on equity-32.26%
Return on investment-31.73%
More ▼

Cash flow in SGDView more

In 2023, Jinhai Medical Technology Ltd increased its cash reserves by 31.27%, or 4.81m. Cash Flow from Financing totalled 13.62m or 29.85% of revenues. In addition the company used 1.91m for operations while cash used for investing totalled 6.51m.
Cash flow per share-0.0405
Price/Cash flow per share--
Book value per share0.175
Tangible book value per share0.175
More ▼

Balance sheet in SGDView more

Jinhai Medical Technology Ltd has a Debt to Total Capital ratio of 23.07%, a higher figure than the previous year's 5.17%.
Current ratio1.54
Quick ratio1.43
Total debt/total equity0.3007
Total debt/total capital0.2307
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.